What is LOPJLB’s current signal on ABP?

LOPJLB’s latest quantitative signal on Abpro Corporation (ABP) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ABP in?

Abpro Corporation (ABP) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Abpro Corporation (ABP) do?

Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-…

Abpro Corporation (ABP)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.12+0.00%Close

SELLCRISIS · day 61

[SCORES & PROFILE]

FUND: 15
VALUE: 13
GROWTH: 35
GARP: 6
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC16.6%

REV YoY-

ROE27.6%

EPS YoY-

ROA-272.5%

GROSS

NET

[VALUATION]

P/E TTM-0.24

P/E FWD-

SECTOR PE20.54

INDUSTRY PE14.03

P/B-0.08

P/FCF-

EV/EBITDA-0.22

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO0.07

ND/EBITDA-

BETA-0.00

FAQ

What is LOPJLB’s current signal on ABP?: LOPJLB’s latest quantitative signal on Abpro Corporation (ABP) is SELL in a CRISIS regime. Signals are updated daily.
What market regime is ABP in?: Abpro Corporation (ABP) is currently classified in the CRISIS HMM market regime on LOPJLB.
What does Abpro Corporation (ABP) do?: Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-…

Abpro Corporation (ABP)

Key stats

Prediction markets

FUNDAMENTALS

Company news

FAQ